These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20686797)

  • 21. Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.
    Al Nimer F; Thelin E; Nyström H; Dring AM; Svenningsson A; Piehl F; Nelson DW; Bellander BM
    PLoS One; 2015; 10(7):e0132177. PubMed ID: 26136237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
    Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
    J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
    Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
    Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
    Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
    Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
    Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
    J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
    Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients.
    Kleine TO; Benes L; Zöfel P
    Brain Res Bull; 2003 Aug; 61(3):265-79. PubMed ID: 12909297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children.
    Beers SR; Berger RP; Adelson PD
    J Neurotrauma; 2007 Jan; 24(1):97-105. PubMed ID: 17263673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: a diagnostic validity.
    Shiihara T; Miyake T; Izumi S; Watanabe M; Kamayachi K; Kodama K; Nabetani M; Ikemiyagi M; Yamaguchi Y; Sawaura N
    Pediatr Int; 2012 Feb; 54(1):52-5. PubMed ID: 21883688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.
    Rainey T; Lesko M; Sacho R; Lecky F; Childs C
    Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of cerebral damage during delirium in elderly patients with hip fracture.
    van Munster BC; Korse CM; de Rooij SE; Bonfrer JM; Zwinderman AH; Korevaar JC
    BMC Neurol; 2009 May; 9():21. PubMed ID: 19473521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum biomarker concentrations and outcome after pediatric traumatic brain injury.
    Berger RP; Beers SR; Richichi R; Wiesman D; Adelson PD
    J Neurotrauma; 2007 Dec; 24(12):1793-801. PubMed ID: 18159990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
    Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
    J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
    Park DW; Park SH; Hwang SK
    Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study.
    Streitbürger DP; Arelin K; Kratzsch J; Thiery J; Steiner J; Villringer A; Mueller K; Schroeter ML
    PLoS One; 2012; 7(8):e43284. PubMed ID: 22916238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.
    Steiner J; Bielau H; Bernstein HG; Bogerts B; Wunderlich MT
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1284-7. PubMed ID: 17043297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia.
    Massaro AN; Chang T; Kadom N; Tsuchida T; Scafidi J; Glass P; McCarter R; Baumgart S; Vezina G; Nelson KB
    J Pediatr; 2012 Sep; 161(3):434-40. PubMed ID: 22494878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of serum S100B levels in neurointensive care.
    Undén J; Astrand R; Waterloo K; Ingebrigtsen T; Bellner J; Reinstrup P; Andsberg G; Romner B
    Neurocrit Care; 2007; 6(2):94-9. PubMed ID: 17522791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.